Dr. Raj Vuppalanchi is a Professor of Medicine at Indiana University School of Medicine. He joined the division in 2007 after completing dual fellowships in Clinical Pharmacology and Gastroenterology-Hepatology from Indiana University School of Medicine. His clinical and research interests are in the areas of non-alcoholic fatty liver disease, non-alcoholic steatohepatitis (NASH), cholestatic and autoimmune liver disease (PSC, PBC, and AIH), biomarkers of fibrosis (transient elastography), and novel therapeutics for various liver disorders. He has expertise in hepatic safety of drugs and herbal and dietary supplements. He serves as a clinical investigator for industry and NIH-sponsored (NASH CRN and DILIN) multi-center clinical trials. He serves as the primary investigator for the Indiana CTSI phase I clinical trials in the hepatic-impaired patient population.